Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.2B | 5.7B | 4.1B | 4.3B |
Cost of revenue | 3.8B | 4.9B | 3.7B | 3.9B |
Gross profit | 367M | 803M | 421M | 408M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 16M | 222M | 32M | 67M |
Operating income | 193M | 607M | 238M | 241M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 13M | 85M | — | 16M |
Other income expense | — | — | — | — |
Pretax income | 154M | 954M | 192M | 542M |
Tax provision | 39M | 161M | 17M | 80M |
Net income | 396M | 429M | 175M | 96M |
Basic EPS | 0.7 | 0.7 | 0.3 | 0.1 |
Diluted EPS | 0.7 | 0.7 | 0.3 | 0.1 |
Basic average shares | 576.4M | 576.6M | 575.3M | 576.6M |
Diluted average shares | 576.4M | 576.6M | 575.3M | 576.6M |
EBITDA | 335M | 1.2B | 393M | 740M |
Net income from continuing op. | — | — | — | — |
Minority interests | -19M | -34M | — | -17M |
Preferred stock dividends | 0 | 0 | 0 | 0 |